Comparing inhaled colistin with inhaled fosfomycin/tobramycin as an adjunctive treatment for ventilator-associated pneumonia: An open-label randomized controlled trial.
Atousa HakamifardAbbas Ali Torfeh EsfahaniAlireza HomayouniFarzin KhorvashBehrooz AtaeiSaeed AbbasiPublished in: The clinical respiratory journal (2023)
The use of inhaled tobramycin/fosfomycin in cases with XDR A. bumannii VAP was associated with a shorter treatment duration in this open-label trial.
Keyphrases
- randomized controlled trial
- study protocol
- open label
- cystic fibrosis
- clinical trial
- drug resistant
- gram negative
- escherichia coli
- multidrug resistant
- phase ii
- systematic review
- squamous cell carcinoma
- intensive care unit
- urinary tract infection
- combination therapy
- klebsiella pneumoniae
- acute respiratory distress syndrome